NCT06738589

Brief Summary

The goal of this clinical trial is to understand the impact of the size and shape of the soft palate on gas airflow in the upper airway in healthy volunteers. Utilizing Magnetic Resonance Imaging (MRI), this study aims to investigate:

  • How does soft palate anatomy change in different body positions?
  • What is the impact of positive pressure therapy, in the form of non-invasive ventilation (NIV) on soft palate anatomy? Researchers will compare MRI data without positive pressure to with positive pressure imaging to see if the addition of positive pressure impacts the size and shape of the soft palate. Researchers will also utilize measures of upper airway resistance to assess the impact of soft palate anatomy of airflow dynamics. Participants will be asked to:
  • Lie inside an MRI scanner for up to 90 minutes (including breaks), in different body positions
  • Undergo NIV therapy for 5-10 minutes while breathing normally inside an MRI scanner
  • Have their upper airway resistance measured, in different body positions

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
15mo left

Started Mar 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Mar 2025Aug 2027

First Submitted

Initial submission to the registry

December 2, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 17, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

March 25, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 25, 2026

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Expected
Last Updated

March 5, 2025

Status Verified

March 1, 2025

Enrollment Period

10 months

First QC Date

December 2, 2024

Last Update Submit

March 3, 2025

Conditions

Keywords

Soft PalateMRINIVAirway

Outcome Measures

Primary Outcomes (1)

  • Volumetric change of soft palate airway size in delta millimeters cubed,

    millimeters cubed

    Single 2 hour visit

Secondary Outcomes (2)

  • Impact of positive pressure ventilation on airway volume in millimeters cubed,

    Single 2 hour visit

  • Upper airway resistance measurements

    Single 2 hour visit

Study Arms (2)

MRI without positive pressure therapy

NO INTERVENTION

Healthy volunteers having their upper airway scanned with MRI without the addition of positive airway pressure therapy (NIV)

MRI with positive pressure

EXPERIMENTAL

Healthy volunteers having their upper airway scanned with MRI with the addition of positive airway pressure therapy (NIV)

Device: non-invasive ventilation

Interventions

Non-invasive ventilation adds positive pressure to the upper airway via a mask on the face.

MRI with positive pressure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adults aged 18+
  • Willing and able to consent to the study

You may not qualify if:

  • Contraindications for MRI (such as metal implants)
  • Contraindications for NIV (such as pneumothorax)
  • No history of lung or upper airway disease
  • Claustrophobia
  • Symptoms of a cold, flu, or significant congestion, within the last 3 days
  • Self-reported confirmed or suspected pregnancy
  • Palatal abnormalities or previous upper airway surgery (such as cleft palate and/or UPPP)
  • Prior major head or neck surgery with or without irradiation (such as radiotherapy of cutaneous cancers, robotic surgery for an oropharyngeal cancer)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Auckland

Auckland, New Zealand

Location

MeSH Terms

Interventions

Noninvasive Ventilation

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Alys Clark

    University of Auckland, New Zealand

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SEQUENTIAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 2, 2024

First Posted

December 17, 2024

Study Start

March 25, 2025

Primary Completion

January 25, 2026

Study Completion (Estimated)

August 1, 2027

Last Updated

March 5, 2025

Record last verified: 2025-03

Locations